{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:27:32Z","timestamp":1773235652512,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jsat.2012.01.010","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T15:46:21Z","timestamp":1331221581000},"page":"115-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment"],"prefix":"10.1016","volume":"44","author":[{"given":"Andrew H.","family":"Talal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rositsa B.","family":"Dimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Seewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond H.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Zeremski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don C.","family":"Des Jarlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2012.01.010_bb0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/10550887.2011.554780","article-title":"Barriers to providing health services for HIV\/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States","volume":"30","author":"Bini","year":"2011","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2012.01.010_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ADM.0b013e318190f0e7","article-title":"Disparities in health services for HIV\/AIDS, hepatitis C virus, and sexually transmitted infections: Role of substance abuse treatment programs","volume":"3","author":"Brown","year":"2009","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2012.01.010_bb0015","doi-asserted-by":"crossref","unstructured":"Davis, G. L., Alter, M. J., El-Serag, H., Poynard, T., & Jennings, L. W., (2010). Aging of hepatitis C virus (HCV)-infected persons in the United States: A multiple cohort model of HCV prevalence and disease progression. Gastroenterology, 138, 513\u2013521, 521 e511\u2013e516.","DOI":"10.1053\/j.gastro.2009.09.067"},{"key":"10.1016\/j.jsat.2012.01.010_bb0020","doi-asserted-by":"crossref","unstructured":"El-Serag, H., Lok, A. S., & Thomas, D. L., (2010). The dawn of a new era: Transforming our domestic response to hepatitis B & C. Gastroenterology, 138, 1225\u20131230, e1221\u2013e1223.","DOI":"10.1053\/j.gastro.2010.02.034"},{"key":"10.1016\/j.jsat.2012.01.010_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.09.008","article-title":"Barriers associated with the treatment of hepatitis C virus infection among illicit drug users","volume":"93","author":"Grebely","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.01.010_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses","volume":"149","author":"Hagan","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.jsat.2012.01.010_bb0035","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2012.01.010_bb0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2105\/AJPH.91.1.46","article-title":"Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif","volume":"91","author":"Lorvick","year":"2001","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2012.01.010_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2893.2010.01411.x","article-title":"Integrated internist\u2013addiction medicine\u2013hepatology model for hepatitis C management for individuals on methadone maintenance","volume":"19","author":"Martinez","year":"2012","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.jsat.2012.01.010_bb0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2008","journal-title":"Journal of Community Health"},{"key":"10.1016\/j.jsat.2012.01.010_bb0055","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1525-1497.2005.0161.x","article-title":"Barriers to the treatment of hepatitis C. Patient, provider, and system factors","volume":"20","author":"Morrill","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2012.01.010_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugpo.2007.02.003","article-title":"Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S","volume":"19","author":"Munoz-Plaza","year":"2008","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2012.01.010_bb0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/02791072.2006.10399849","article-title":"Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs","volume":"38","author":"Munoz-Plaza","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2012.01.010_bb0070","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2012.01.010_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11524-007-9180-8","article-title":"Offers of hepatitis C care do not lead to treatment","volume":"84","author":"Schackman","year":"2007","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.jsat.2012.01.010_bb0080","author":"Seewald","year":"2010"},{"key":"10.1016\/j.jsat.2012.01.010_bb0085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.285.8.1003","article-title":"Former addicts face barriers to treatment for HCV","volume":"285","author":"Stephenson","year":"2001","journal-title":"Journal of American Medical Association"},{"issue":"Suppl 5","key":"10.1016\/j.jsat.2012.01.010_bb0090","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1086\/427445","article-title":"Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users","volume":"40","author":"Strathdee","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2012.01.010_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6963-7-39","article-title":"Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services","volume":"7","author":"Strauss","year":"2007","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.jsat.2012.01.010_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2190\/3EMQ-N350-W4XN-WT1X","article-title":"Hepatitis C knowledge among staff in U.S. drug treatment programs","volume":"36","author":"Strauss","year":"2006","journal-title":"Journal of Drug Education"},{"key":"10.1016\/j.jsat.2012.01.010_bb0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/00952990601174899","article-title":"Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs","volume":"33","author":"Strauss","year":"2007","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2012.01.010_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0740-5472(01)00213-6","article-title":"A nationwide survey of hepatitis C services provided by drug treatment programs","volume":"22","author":"Strauss","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2012.01.010_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","article-title":"Correlates of hepatitis C virus infections among injection drug users","volume":"74","author":"Thomas","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jsat.2012.01.010_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550880802544625","article-title":"Substance abuse treatment clinician opinions and infectious disease service delivery","volume":"28","author":"Tracy","year":"2009","journal-title":"Journal of Addict Diseases"},{"key":"10.1016\/j.jsat.2012.01.010_bb0125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2893.2009.01250.x","article-title":"Uptake and delivery of hepatitis C treatment in opiate substitution treatment: Perceptions of clients and health professionals","volume":"17","author":"Treloar","year":"2010","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.jsat.2012.01.010_bb0130","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21765","article-title":"Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000","volume":"46","author":"Tseng","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jsat.2012.01.010_bb0135","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.23220","article-title":"Public health impact of antiviral therapy for hepatitis C in the United States","volume":"50","author":"Volk","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jsat.2012.01.010_bb0140","unstructured":"World Health Organization. (2002). Hepatitis C. Available at: http:\/\/www.who.int\/csr\/disease\/hepatitis\/Hepc.pdf. Accessed: August 1, 2010"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547212000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547212000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:37:44Z","timestamp":1760038664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547212000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0740547212000232"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2012.01.010","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2012.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}